^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

POLE mutation

i
Other names: POLE1, DNA Polymerase Epsilon Catalytic Subunit, DNA Polymerase Epsilon Catalytic Subunit A, Polymerase (DNA) Epsilon Catalytic Subunit, DNA Polymerase II Subunit A, Polymerase (DNA Directed) Epsilon Catalytic Subunit, DNA Polymerase Epsilon Catalytic Subunit Protein, Polymerase (DNA Directed) Epsilon
Entrez ID:
Related biomarkers:
POLE mutation
Solid Tumor
Immunotherapy
Sensitive
:
B
POLE mutation
Endometrial Cancer
pembrolizumab
Sensitive
:
C2
POLE mutation
Gastric Cancer
CP-675206
Sensitive
:
C2
POLE mutation
Gastric Cancer
durvalumab
Sensitive
:
C2
POLE mutation
Solid Tumor
avelumab
Sensitive
:
C2
POLE mutation
Endometrial Cancer
avelumab
Sensitive
:
C2
POLE mutation
Solid Tumor
toripalimab
Sensitive
:
C2
POLE mutation
Colorectal Cancer
nivolumab
Sensitive
:
C2
POLE mutation
Solid Tumor
dostarlimab
Sensitive
:
C2
POLE mutation
Melanoma
PD1 inhibitor + PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Cholangiocarcinoma
PD1 inhibitor + PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Non Small Cell Lung Cancer
PD1 inhibitor + PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Colorectal Cancer
PD1 inhibitor + PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Melanoma
PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Cholangiocarcinoma
PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Non Small Cell Lung Cancer
PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Colorectal Cancer
PD-L1 inhibitor
Sensitive
:
C3
POLE mutation
Melanoma
PD1 inhibitor
Sensitive
:
C3
POLE mutation
Cholangiocarcinoma
PD1 inhibitor
Sensitive
:
C3
POLE mutation
Non Small Cell Lung Cancer
PD1 inhibitor
Sensitive
:
C3
POLE mutation
Colorectal Cancer
PD1 inhibitor
Sensitive
:
C3
POLE mutation
Colorectal Cancer
nivolumab + ipilimumab
Sensitive
:
C3
POLE mutation
Gastroesophageal Cancer
Immunotherapy
Sensitive
:
C3
POLE mutation
Non Small Cell Lung Cancer
Immunotherapy
Sensitive
:
C3
POLE mutation
Endometrial Cancer
nivolumab
Sensitive
:
C4